Bain, Cinven Weigh Sale of €10 Billion Drugmaker Stada (1)

The private equity owners of Stada Arzneimittel AG are weighing options for the German drugmaker, including a possible sale, people with knowledge of the matter said.

Bain Capital and Cinven are in the early stages of asking banks to pitch for roles on a possible transaction, the people said, asking not to be identified discussing confidential information. A sale could value Stada at €10 billion ($10.1 billion) or more, the people said.

The private equity firms are prepared to explore a range of options for Stada, including a sale that excludes its operations in Russia, one of the people said. ...